[In HIV-HCV co-infection check for drug interactions].
.
Judith
J
Neumaier
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D002219:Carbamates; D057176:Compassionate Use Trials; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D011759:Pyrrolidines; D012254:Ribavirin / Q000008:administration & dosage; D000069474:Sofosbuvir / Q000008:administration & dosage / Q000009:adverse effects; D014633:Valine / Q000031:analogs & derivatives; D006801:Humans
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D002219:Carbamates; C549273:daclatasvir; D007093:Imidazoles; D011759:Pyrrolidines; D012254:Ribavirin; D000069474:Sofosbuvir; D014633:Valine